ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,509Medicare Part D Prescriptions Filled, Including Refills

Rank: 86 out of 6645

$2.5M Total Retail Price of All Prescriptions

Rank: 52 out of 6645

750 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 750 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 23,486 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$102 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 961 939 1 1
AMLODIPINE BESYLATE 844 825 2 2
METFORMIN HCL 774 748 3 7
ATORVASTATIN CALCIUM 675 660 4 10
EVISTA 632 625 5 90
METOPROLOL SUCCINATE 596 574 6 24
OMEPRAZOLE 578 554 7 6
METFORMIN HCL ER 556 544 8 89
DIOVAN 453 447 9 19
PRAVASTATIN SODIUM 385 351 10 20
NAMENDA 381 377 11 41
BACLOFEN 375 370 12 100
CARVEDILOL 372 350 13 25
LOSARTAN POTASSIUM 360 355 14 12
JANUVIA 332 323 15 38
ADVAIR DISKUS 328 306 16 45
DONEPEZIL HCL 313 309 17 27
HYDROCODONE-ACETAMINOPHEN 308 304 S3 18 5
CRESTOR 296 285 19 34
TAMSULOSIN HCL 293 284 20 22
LEVOFLOXACIN 285 280 21 83
ACARBOSE 284 280 22 211
ZOLPIDEM TARTRATE 282 273 23 17
SPIRIVA 274 272 24 65
PANTOPRAZOLE SODIUM 272 248 25 29
LEVOTHYROXINE SODIUM 270 257 26 4
FUROSEMIDE 252 229 27 11
LEVOCETIRIZINE DIHYDROCHLORIDE 242 236 28 241
AVODART 242 237 28 99
LIPITOR 234 232 30 69
ATENOLOL 231 230 31 8
AMLODIPINE BESYLATE-BENAZEPRIL 231 218 31 97
MIRTAZAPINE 230 219 33 70
ALLOPURINOL 229 219 34 31
RAMIPRIL 226 214 35 118
FINASTERIDE 225 221 36 73
ALENDRONATE SODIUM 220 214 37 14
LANTUS 216 192 38 50
CLOPIDOGREL 203 190 39 36
METOPROLOL TARTRATE 191 183 40 13
ISOSORBIDE MONONITRATE ER 178 167 41 66
LISINOPRIL 177 169 42 3
ACTOS 176 176 43 71
FLUTICASONE PROPIONATE 174 172 44 26
NOVOLOG 170 153 45 144
TRIAMCINOLONE ACETONIDE 168 165 46 55
DIOVAN HCT 166 166 47 64
BENAZEPRIL HCL 161 158 48 21
SINGULAIR 158 157 49 76
PREDNISONE 144 143 50 57
ULTICARE 141 139 10 51 433
BENICAR 138 138 52 84
PLAVIX 137 131 53 49
LYRICA 123 123 54 127
GLIMEPIRIDE 122 116 55 47
GLYBURIDE-METFORMIN HCL 119 116 R 56 95
ATELVIA 117 111 57 91
FAMOTIDINE 115 115 58 33
QUETIAPINE FUMARATE 114 108 59 101
MECLIZINE HCL 105 103 60 122
TRIAMTERENE-HCTZ 104 96 61 52
GABAPENTIN 99 88 62 18
SINGLE USE SWAB 97 97 63 350
AMIODARONE HCL 96 91 64 160
COLCRYS 96 94 64 192
BISOPROLOL-HYDROCHLOROTHIAZIDE 95 88 66 339
LOSARTAN-HYDROCHLOROTHIAZIDE 94 94 67 62
EXELON 92 92 68 149
DILTIAZEM ER 91 90 69 182
LOVASTATIN 91 91 69 15
HUMALOG 90 74 71 137
NEXIUM 89 81 72 40
HYDRALAZINE HCL 87 82 73 77
SYMBICORT 86 86 74 153
VESICARE 85 85 75 148
MONTELUKAST SODIUM 84 82 76 128
RANITIDINE HCL 83 83 77 51
METOCLOPRAMIDE HCL 83 73 77 120
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 81 79 37
AZITHROMYCIN 80 78 80 44
CELEBREX 80 80 80 54
CLONIDINE HCL 76 67 82 56
HYDROCHLOROTHIAZIDE 76 76 82 9
DOXYCYCLINE HYCLATE 76 75 82 198
ZETIA 73 64 85 87
HYDROCORTISONE 73 69 85 229
CARBIDOPA-LEVODOPA 72 72 87 116
NIFEDIPINE ER 69 69 88 82
EXFORGE 68 68 89 155
ONGLYZA 67 67 90 168
WARFARIN SODIUM 66 64 91 16
DEXILANT 63 63 92 102
MEGESTROL ACETATE 62 62 R 93 104
PREMARIN 61 59 R 94 169
GLIPIZIDE 60 55 95 23
MELOXICAM 59 58 96 46
POTASSIUM CHLORIDE 59 59 96 28
LACTULOSE 58 57 98 125
METHYLPREDNISOLONE 57 56 99 249
AMOX TR-POTASSIUM CLAVULANATE 56 53 100 185
IPRATROPIUM-ALBUTEROL 56 12 100 201
PROAIR HFA 56 49 100 32
LIDODERM 55 55 103 53
CLOTRIMAZOLE-BETAMETHASONE 55 55 103 177
PIOGLITAZONE HCL 53 53 R 105 184
BYSTOLIC 50 50 106 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.